Condition
Symbiotic
Total Trials
4
Recruiting
2
Active
2
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 4 trials
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
4Total
Not Applicable (3)
P 4 (1)
Trial Status
Recruiting2
Not Yet Recruiting1
Unknown1
Clinical Trials (4)
Showing 4 of 4 trials
NCT07461233Not ApplicableRecruitingPrimary
Modulation of Gut Microbiota Composition and Gut Permeability Profiles by Multispecies Synbiotic Supplementation in Hemodialysis Patients
NCT07443280Not ApplicableRecruitingPrimary
Alterations of Gut Derived Uremic Toxins and Microbiome Metabolites by Multispecies Synbiotic
NCT07483697Not ApplicableNot Yet Recruiting
Multimodal Intervention for Early Chronic Kidney Disease in Young People: Dysbiosis and Inflammation (CKD)
NCT04874883Phase 4UnknownPrimary
Effect of the Use of Symbiotics in Patients With Colon Cancer
Showing all 4 trials